Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Clinical trial NCT03137407 · COMPLETED
Trial details
- NCT number
- NCT03137407
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2018-02-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.